Segments of Business and Geographic Areas (Tables)

6 Months Ended

Jul. 03, 2011

Segments of Business and Geographic Areas [Abstract]

Sales by segment of business

SALES BY SEGMENT OF BUSINESS

	Fiscal Quarters Ended
	July 3,		July 4,		Percent
(Dollars in Millions)	2011		2010		Change
Consumer
U.S.	$	1,339	$	1,463		(8.5	)%
International		2,454		2,184		12.4
Total		3,793		3,647		4.0
Pharmaceutical
U.S.		3,239		3,110		4.1
International		2,994		2,443		22.6
Total		6,233		5,553		12.2
Medical Devices & Diagnostics
U.S.		2,869		2,865		0.1
International		3,702		3,265		13.4
Total		6,571		6,130		7.2
Worldwide
U.S.		7,447		7,438		0.1
International		9,150		7,892		15.9
Total	$	16,597	$	15,330		8.3	%

	Fiscal Six Months Ended
	July 3,		July 4,		Percent
(Dollars in Millions)	2011		2010		Change
Consumer
U.S.	$	2,684	$	3,023		(11.2	)%
International		4,791		4,390		9.1
Total		7,475		7,413		0.8
Pharmaceutical
U.S.		6,630		6,316		5.0
International		5,662		4,875		16.1
Total		12,292		11,191		9.8
Medical Devices & Diagnostics
U.S.		5,741		5,751		(0.2	)
International		7,262		6,606		9.9
Total		13,003		12,357		5.2
Worldwide
U.S.		15,055		15,090		(0.2	)
International		17,715		15,871		11.6
Total	$	32,770	$	30,961		5.8	%

Operating profit by segment of business

OPERATING PROFIT BY SEGMENT OF BUSINESS

	Fiscal Quarters Ended
	July 3,			July 4,			Percent
(Dollars in Millions)	2011			2010			Change
Consumer	$	549		$	669			(17.9	)%
Pharmaceutical (1)		1,714			1,833			(6.5	)
Medical Devices & Diagnostics (2)		1,275			1,876			(32.0	)
Segments operating profit		3,538			4,378			(19.2	)
Expense not allocated to segments (3)		(116	)		(158	)
Worldwide income before taxes	$	3,422		$	4,220			(18.9	)%

	Fiscal Six Months Ended
	July 3,			July 4,			Percent
(Dollars in Millions)	2011			2010			Change
Consumer	$	1,122		$	1,454			(22.8	)%
Pharmaceutical (1)		3,923			3,803			3.2
Medical Devices & Diagnostics (2)		3,219			5,578			(42.3	)
Segments operating profit		8,264			10,835			(23.7	)
Expense not allocated to segments (3)		(332	)		(335	)
Worldwide income before taxes	$	7,932		$	10,500			(24.5	)%

(1)	Includes litigation expense of $290 million and $540 million recorded in the fiscal second quarter and the first fiscal six months of 2011, respectively. The first fiscal six months of 2011 includes a gain related to the Company’s earlier investment in Crucell recorded in the fiscal first quarter of 2011. The fiscal second quarter and the first fiscal six months of 2010, includes net litigation expense of $115 million and $202 million, respectively.
(2)	Includes restructuring expense of $676 million recorded in the fiscal second quarter and first fiscal six months of 2011. Includes litigation expense and additional DePuy ASR™ Hip recall costs of $127 million recorded in the fiscal second quarter of 2011. Includes litigation expense and additional DePuy ASR™ Hip recall costs of $223 million recorded in the first fiscal six months of 2011. Includes net litigation expense of $42 million and income of $1,542 million recorded in the fiscal second quarter and the first fiscal six months of 2010, respectively.
(3)	Amounts not allocated to segments include interest income/(expense), non-controlling interests and general corporate income/(expense).

Sales by geographic area

SALES BY GEOGRAPHIC AREA

	Fiscal Quarters Ended
	July 3,		July 4,		Percent
(Dollars in Millions)	2011		2010		Change
U.S.	$	7,447	$	7,438		0.1	%
Europe		4,543		3,832		18.6
Western Hemisphere, excluding U.S.		1,543		1,375		12.2
Asia-Pacific, Africa		3,064		2,685		14.1
Total	$	16,597	$	15,330		8.3	%

	Fiscal Six Months Ended
	July 3,		July 4,		Percent
(Dollars in Millions)	2011		2010		Change
U.S.	$	15,055	$	15,090		(0.2	)%
Europe		8,726		7,934		10.0
Western Hemisphere, excluding U.S.		2,979		2,655		12.2
Asia-Pacific, Africa		6,010		5,282		13.8
Total	$	32,770	$	30,961		5.8	%